<unk>  is an antineoplastic agent and alkylating agent that is FDA approved for the treatment of metastatic malignant melanoma and also indicated for Hodgkin's disease as a secondary-line therapy when used in combination with other effective agents.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include anorexia, nausea, and vomiting, influenza-like syndrome of fever to 39°C, myalgias, malaise and alopecia.
Dacarbazine
Ifosfamide
Mafosfamide
Busulfan 
Procarbazine
Etoposide 
Melphalan
Satraplatin